Flywheel Exercise for CKD
Flywheel Resistance Exercise to Improve Skeletal Muscle in Veterans With Chronic Kidney Disease
1 other identifier
interventional
20
1 country
1
Brief Summary
Among Veterans, the prevalence of chronic kidney disease (CKD) is reported to be as high as 47.3% and a third higher than the general population. Muscle wasting and dysfunction have been identified as primary consequences of CKD. Disease-induced reductions in lean tissue adversely affect muscle fatigability. Consequently, muscle fatigability may serve as a potential limiting factor that contributes to activity limitations. However, there is a lack of evidence informing our understanding of muscle fatigability in patients with CKD. Dialysis treatment is a major factor contributing to the high financial costs of CKD care. Thus, in addition to potential health and quality of life benefits, treatments capable of maintaining kidney function or delaying the onset of dialysis treatment would provide substantial socio-economic benefit. Both lean body mass and muscle fatigability may be improved through strength training. Eccentric-overload (i.e. muscle lengthening) progressive resistance exercise (PRE) has been shown to be safe and effective for a variety of chronic conditions. Eccentric PRE using portable flywheel technology may provide a clinically viable treatment option to combat muscle impairments in CKD given the cost effectiveness and minimal space requirements for this mode of exercise. The purpose of this study is to assess feasibility of the eccentric-overload PRE regimen for Veterans with CKD stage 3 \& 4 predialysis using a prospective single-arm pre-test post-test intervention design. The primary aim of the project is to determine the effects of eccentric-overload PRE on muscle fatigability in Veterans with CKD Stages 3 \& 4 predialysis. Feasibility of the regimen will be determined by the time needed to complete the 4-exercise regimen and the perceived exertion levels reported by the study participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 16, 2018
CompletedFirst Submitted
Initial submission to the registry
June 15, 2018
CompletedFirst Posted
Study publicly available on registry
July 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2020
CompletedNovember 9, 2018
November 1, 2018
9 months
June 15, 2018
November 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Change in Knee extensor isokinetic muscle fatigability index at 12 weeks
Knee extensor muscle fatigability will be assessed using a protocol consisting of 30 repetitions or to failure, whichever comes first, at their maximum strength
Baseline, Week 12
Change in Muscle blood flow at 12 weeks
Blood flow will be assessed using Doppler ultrasound
Baseline, Week 12
Change in Isokinetic and isometric peak knee extension force at 12 weeks
Unilateral peak knee extension/flexion isokinetic force (at 180º/s and 60º/s) will be obtained across five continuous repetitions using a load cell
Baseline, Week 6, Week 12
Change in Short Physical Performance Battery at 12 weeks
This composite score is made up of measures of balance, gait speed (15 ft), and timed chair stands (x5).
Baseline, Week 12
Change in Timed Up-and-Go at 12 weeks
This test will begin the test with the subject fully sitting in a chair with arm rests, with the upright mobility portion of the test focused on an easily visible marked target 3 meters away from the chair
Baseline, Week 12
Change in Lean Body Mass, as estimated by diagnostic ultrasound at 12 weeks
Sonographic estimates of LBM (aggregate muscle thickness, cm) will serve as a proxy measure for muscle tissue composition in this study
Baseline, Week 6, Week 12
Change in myosteatosis, as estimated by diagnostic ultrasound at 12 weeks
Sonographic estimates of myosteatosis (grayscale, or GSL, values, 0-255) will serve as a proxy measure for muscle tissue composition in this study
Baseline, Week 6, Week 12
Secondary Outcomes (8)
Change in Grip strength at 12 weeks
Baseline, Week 12
Change in Activities-Specific Balance Confidence (ABC) Scale at 12 weeks
Baseline, Week 12
Change in Short Form Health Survey (SF-36) Scale at 12 weeks
Baseline, Week 12
Change in Falls Efficacy Scale (FES) at 12 weeks
Baseline, Week 12
Change in weight at 12 weeks
Baseline, Week 6, Week 12
- +3 more secondary outcomes
Study Arms (1)
Eccentric overload exercise
EXPERIMENTALInterventions
12 weeks of 2x per week of the following eccentric exercises: squat, shoulder press, row, and bicep curl.
Eligibility Criteria
You may qualify if:
- ambulatory patients (with or without a gait aid)
- CKD stage 3 or 4
- patients receiving care at the DC VAMC Renal Service
- the ability to speak and read English
- orientation to person, place, and time
You may not qualify if:
- unable to speak English
- acute renal failure
- pregnant
- unable to follow study instructions
- any uncontrolled cardiovascular or musculoskeletal problems that would make participation in this study unsafe
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington DC VA Medical Center
Washington D.C., District of Columbia, 20422, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Michael O Harris-Love, DSc
Washington DC VA Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2018
First Posted
July 11, 2018
Study Start
May 16, 2018
Primary Completion
February 1, 2019
Study Completion
February 1, 2020
Last Updated
November 9, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share